课题基金 / 基金详情

项目摘要

项目成果

EDWARD F BELL的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Thermoregulation is an important determinant of the survival of very immature infants (i.e., <28 weeks gestation). The optimal temperature range for any infant (term or preterm) is one that minimizes stress and metabolic consumption. If the infant's temperature falls below the lower limit of the optimal temperature range the infant is at risk of hypothermia and any associated complications. Several risk factors are associated with neonatal hypothermia including an increase in morbidity from infection, abnormal coagulation, post-delivery acidosis, delayed readjustment from the fetal to newborn circulation, and respiratory distress syndrome. Very immature infants are particularly vulnerable to heat loss because they lack subcutaneous fat, have an increased surface area to body weight ratio, exhibit poor vasomotor control in the first two or three days of life, and have immature stratum corneum that is relatively deficient in keratin content. In an attempt to reduce heat loss and therefore increase the chances of survival in the premature infant, several inventive protocols and procedures have been proposed and put into practice. Presently, the standard of care for reducing heat loss following birth is to immediately dry newborns under radiant heat. Although this method has been shown to significantly reduce heat loss, there is still considerable room for improvement. This study hypothesizes that occlusive skin wrapping of premature infants under a preheated radiant warmer is more effective than conventional drying for preventing mortality and morbidity related to hypothermia in the premature infant.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Transfusion-Associated Brain Improvement (TABI) trial - CCC
  • 批准号:
    8269508
  • 项目类别:
  • 资助金额:
    $18.45万
  • 财政年份:
    2012
  • 负责人:
    EDWARD F BELL
  • 依托单位:
Transfusion-Associated Brain Improvement (TABI) trial - CCC
  • 批准号:
    8514715
  • 项目类别:
  • 资助金额:
    $23.75万
  • 财政年份:
    2012
  • 负责人:
    EDWARD F BELL
  • 依托单位:
Transfusion-Associated Brain Improvement (TABI) trial - CCC
  • 批准号:
    8849489
  • 项目类别:
  • 资助金额:
    $24.01万
  • 财政年份:
    2012
  • 负责人:
    EDWARD F BELL
  • 依托单位:
PROCALCITONIN, INTERLEUKIN-10, AND CD64 AS MARKERS OF NEONATAL SEPSIS
  • 批准号:
    7604923
  • 项目类别:
  • 资助金额:
    $0.13万
  • 财政年份:
    2007
  • 负责人:
    EDWARD F BELL
  • 依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
  • 批准号:
    2021JJ40433
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2021
  • 负责人:
    孙磊
  • 依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
  • 批准号:
    32001603
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    段真珍
  • 依托单位:
AREA国际经济模型的移植.改进和应用
  • 批准号:
    18870435
  • 项目类别:
    面上项目
  • 资助金额:
    2.0万元
  • 批准年份:
    1988
  • 负责人:
    史树中
  • 依托单位: